Clinical Trials Logo

5'-Nucleotidase Syndrome clinical trials

View clinical trials related to 5'-Nucleotidase Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT00004658 Completed - Clinical trials for 5'-Nucleotidase Syndrome

Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity

Start date: March 1995
Phase: Phase 2
Study type: Interventional

OBJECTIVES: I. Evaluate the efficacy of oral ribose in patients with a complex 5'-nucleotidase syndrome who have not received uridine (UR) and thymidine (TDR). II. Evaluate the efficacy of UR/oral ribose and UR/TDR. III. Evaluate the efficacy of oral ribose given in combination with UR/TDR.